Dr. Zachary Leithman Karam, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 848 Terry Pkwy, Terrytown, LA 70056 Phone: 504-392-4222 |
Dr. Hugh Pierce Champagne, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 761 Wright Ave, Terrytown, LA 70056 Phone: 504-362-8282 Fax: 504-362-8283 |
Dr. Niobe Ali Joseph, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2600 Belle Chasse Hwy Ste 200, Terrytown, LA 70056 Phone: 504-392-9874 Fax: 504-392-9990 |
Dr. Robert Joseph Culver, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 404 Wright Ave, Terrytown, LA 70056 Phone: 504-367-7211 Fax: 504-367-7211 |
Dr. Gerard A Karam Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 848 Terry Pkwy, Terrytown, LA 70056 Phone: 504-392-4222 Fax: 504-392-0968 |
Dr. Robert Joseph Graziano, D.D.S Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 848 Terry Pkwy, Terrytown, LA 70056 Phone: 504-391-0114 |
Dr. Kim Chi Nguyen Do, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 441 Terry Pkwy Ste B, Terrytown, LA 70056 Phone: 504-319-5256 |
News Archive
"[E]xplicit indicators to measure progress in reducing heart diseases, stroke, diabetes, cancers and chronic respiratory diseases" are missing from the U.N. Economic and Social Council (ECOSOC) agenda as it meets in Geneva this week "to focus on implementing the internationally agreed goals and commitments in regard to public health," and the "omission needs to be urgently addressed if the intent is to have a major impact on reducing poverty by 2015," Ala Alwan, WHO's assistant director-general for Noncommunicable Diseases and Mental Health; George Alleyne, PAHO's director emeritus; and Martin Silink, president of the International Diabetes Federation write in an opinion piece in the Hindu.
LSTM's Senior Clinical Lecturer, Dr Shevin Jacob is corresponding author on a perspective piece published in the New England Journal of Medicine calling for universal standards of care to be applied in relation to Ebola Virus Disease.
Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 50 mg, 100 mg, 150mg, 200 mg, and 250mg strength armodafinil tablets prior to the expiration of patents owned by Cephalon France.
› Verified 1 days ago